The synthesis of the title compound is described in [1] . Single crystals suitable for X-ray diffraction were obtained by slow evaporation at 4 °C from a MeOH/FhO mixture.
Discussion
Two predominant classes of HIV-1 integrase (IN) inhibitors are the catechol-containing hydroxylated aromatics and the diketo acid-containing aromatics [2] . Recently, a series of 5//-pyrano-[2,3-d:-6,5-d']dipyrimidines (PDPs) has been identified as a new class of inhibitors that interferes with HIV-1 and HIV-2 integration in cell culture [3] . The most potent congener of this class V-165 inhibits HIV-1 replication in cell culture and inhibits IN and reverse transcriptase (RT) activity in enzymatic assays at μΜ concentrations [3] . V-165 is equally active against virus strains that were resistant to both inhibitors of viral entry or reverse transcription [3] . V-165 interferes with the viral replication cycle at a point coinciding with proviral DNA integration, confirmed by quantitative Alu-PCR [3] . Diketo acid-resistant strains remained fiilly sensitive to V-165 [4] , assuming a different mechanism of action which remains subject of further investigation. The title compound is in fact the open form and intermediate in the synthesis of V-165. This open form also has interesting biological properties such as antibacterial and antiherpes activity [1] , but no IN inhibition. Although we initially intended to crystallize V-165, the open form was obtained. The ring opening was not initiated by the crystallization conditions, but by mistake probably caused during the purification procedure. However, this structure can still contribute to the further knowledge and development of HIV therapeutics. The title compound crystallizes centrosymmetrically with one molecule, one pyridine cation and two solvent molecules (MeOH and H2O) per asymmetric unit. The two pyrimidine rings (best planes through the six-membered rings) make an angle of 60.1 (2)°, hence forming a 'butterfly' structure. The nitrophenyl ring, positioned on top of the 'butterfly' structure makes angles of 84.6(3)° and 64.4(3)° with the two respective pyrimidine rings. The orientation of the nitrophenyl ring is further described by torsion angles C21-C20-C10-C5 (58.6(6)°) and C25-C20-C10-C15 (11.0(8)°), making the nitrophenyl ring torsioned with respect to the pyrimidine rings. The nitro group of the nitrophenyl ring is almost planar with the phenyl ring (angle of 4.1(3)°). Hydrogen atom H8 is observed at an intermediate position between oxygen atoms O8 and 019 (distances H8-O8 and H8-019 are 1.27(4) A and 1.27(5) A, respectively). This is compatible with the similar distances observed in both pyrimidine moieties. Hydrogen atom H32 of the pyridinium group makes two hydrogen bonds with atoms 09 and 018 (distances are 2.06 A and 2.51 A, respectively). The solvents water and methanol are hydrogenbonded with each other and with the molecule. The packing is dominated by infinite chains running in the α-direction and formed by hydrogen bonds between the thioamide functions. (7) 0.0071 (7) 0.0112(6) 0.0146 (7 
